multidrug-resistant tuberculosis
Johnson & Johnson Offers Global Access by Not Enforcing Sirturo’s Tuberculosis Drug Secondary Patents
Anika Sharma
Johnson & Johnson has taken significant steps to improve access to its multidrug-resistant tuberculosis (MDR-TB) medication, Sirturo (bedaquiline), in low- ...
